Advertisement

Biomarkers of Spontaneous Preterm Birth: An Overview of The Literature in the Last Four Decades

Abstract

Background

Understanding spontaneous preterm birth ([PTB] < 37 weeks) is difficult due to heterogeneities associated with multitudes of risk factors and pathophysiological pathways. Several biomarkers are routinely used clinically for predicting preterm labor; however, these factors are either nonspecific or detected too late.

Objective

Systematic review of literature on PTB biomarkers in the last 40 years to map out the existing knowledge and gaps in understanding PTB biomarkers. Search strategies: Five electronic databases were searched for human studies on PTB biomarkers published in any language between 1965 and 2008. Selection criteria: The phenotype of interest for final data extraction was exclusively spontaneous PTB with no rupture of membranes. Data extraction included (a) general characteristics of the study (clinical setting, period, and study design), (b) study/participant characteristics (inclusion and exclusion criteria, race/ethnicity, number of participants, gestational age at sampling, (c) characteristics of the biomarker (type, rationale for its selection, type of biological sample, and assay used, and (d) concentration of biomarkers in cases and controls. Data collection and analysis: The search yielded 7255 citations and data were extracted from 217 articles which met our inclusion and exclusion criteria.

Main results

A total of 116 different biomarkers were reported and these were assayed 578 times in the 217 included studies. Over two thirds of the 217 studies were performed on North American or European populations. No reliable biomarkers emerged as a risk predictor of PTB.

Conclusions

Identifying similar studies on biomarkers for the prediction of PTB was a very challenging task due heterogeneities in study design, sampling issues (types, timing and processing), assay methods, and analyses. Major areas of concern identified in this review include poor phenotype definition, nonideal study designs and poor rationale for biomarker selection and assays and population stratification issues.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 510

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Menon R. Spontaneous preterm birth, a clinical dilemma: etiolo-gic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand. 2008;87(6):590–600.

  2. 2.

    Demissie K, Rhoads GG, Ananth CV, et al. Trends in preterm birth and neonatal mortality among blacks and whites in the United States from 1989 to 1997 Am J Epidemiol. 2001;154(4): 307–315.

  3. 3.

    Fiscella K. Race, genes and preterm delivery. J Natl Med Assoc. 2005;97(11):1516–1526.

  4. 4.

    Committee on Understanding Premature Birth and Assuring Healthy Outcomes. In: Berhman RE, Butler AS, eds. Preterm Birth: Causes, Consequences and Prevention. Washington DC, The National Academies Press; 2006. Ref Type: Serial (Book, Monograph).

  5. 5.

    March of Dimes. Preterm Births Rise 36 Percent Since Early 1980s. (2009);9-12-2010. Ref Type: Online Source.

  6. 6.

    Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31–38.

  7. 7.

    Faron G, Boulvain M, Irion O, Bernard PM, Fraser WD. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol. 1998;92(1):153–158.

  8. 8.

    Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ. 2002;325(7359):301.

  9. 9.

    Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol. 2003;22(3):305–322.

  10. 10.

    Honest H, Bachmann LM, Sengupta R, Gupta JK, Kleijnen J, Khan KS. Accuracy of absence of fetal breathing movements in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol. 2004;24(1):94–100.

  11. 11.

    Honest H, Bachmann LM, Sundaram R, Gupta JK, Kleijnen J, Khan KS. The accuracy of risk scores in predicting preterm birth-a systematic review J Obstet Gynaecol. 2004;24(4): 343–359.

  12. 12.

    Honest H, Bachmann LM, Knox EM, Gupta JK, Kleijnen J, Khan KS. The accuracy of various tests for bacterial vaginosis in predicting preterm birth: a systematic review BJOG. 2004;111(5): 409–422.

  13. 13.

    Mozurkewich EL, Naglie G, Krahn MD, Hayashi RH. Predicting preterm birth: a cost-effectiveness analysis. Am J Obstet Gynecol. 2000;182(6):1589–1598.

  14. 14.

    Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG. 2007;114(7):796–801.

  15. 15.

    Yuan W, Chen L, Bernal AL. Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2009;145(1):57–64.

  16. 16.

    Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323(7305):157–162.

  17. 17.

    Irwig L, Tosteson AN, Gatsonis C, et al. Guidelines for metaanalyses evaluating diagnostic tests Ann Intern Med. 1994;120(8): 667–676.

  18. 18.

    Khan KS, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests Eur J Obstet Gynecol Reprod Biol. 2001;95(1): 6–11.

  19. 19.

    Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.

  20. 20.

    Bodnar LM, Simhan HN. Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv. 2010;65(4):273–284.

  21. 21.

    Menon R, Merialdi M, Lombardi SJ, Fortunato SJ. Differences in the placental membrane cytokine response: a possible explanation for the racial disparity in preterm birth. Am J Reprod Immunol. 2006;56(2):112–118.

  22. 22.

    Menon R, Williams SM, Fortunato SJ. Amniotic fluid interleukin-1beta and interleukin-8 concentrations: racial disparity in preterm birth. Reprod Sci. 2007;14(3):253–259.

  23. 23.

    Menon R, Camargo MC, Thorsen P, Lombardi SJ, Fortunato SJ. Amniotic fluid interleukin-6 increase is an indicator of spontaneous preterm birth in white but not black Americans. Am J Obstetr Gynecol. 2008;198(5):77.

  24. 24.

    Menon R, Thorsen P, Vogel I, et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-(alpha) and soluble TNF receptors in spontaneous preterm birth. Am J Obstetr Gynecol. 2008;198(5):533.

  25. 25.

    Ryckman KK, Simhan HN, Krohn MA, Williams SM. Cervical cytokine network patterns during pregnancy: the role of bacterial vaginosis and geographic ancestry. J Reprod Immunol. 2009;79(2):174–182.

  26. 26.

    Tsourapas A, Roberts TE, Barton PM, et al. An economic evaluation of alternative test-intervention strategies to prevent spontaneous pre-term birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88(12):1319–1330.

  27. 27.

    Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30(10):918–949.

  28. 28.

    Honest H, Forbes CA, Duree KH, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2009;13(43):1–627.

  29. 29.

    Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010;116(2 pt 1):393–401.

  30. 30.

    Curry AE, Thorsen P, Drews C, et al. First-trimester maternal plasma cytokine levels, pre-pregnancy body mass index, and spontaneous preterm delivery. Acta Obstet Gynecol Scand. 2009;88(3):332–342.

  31. 31.

    Gargano JW, Holzman C, Senagore P, et al. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth J Reprod Immunol. 2008;79(1): 100–110.

  32. 32.

    Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B. Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids. Obstet Gynecol. 2009;114(2 pt 1):268–277.

  33. 33.

    Mestan K, Yu Y, Thorsen P, et al. Cord blood biomarkers of the fetal inflammatory response. J Matern Fetal Neonatal Med. 2009;22(5):379–387.

  34. 34.

    Skogstrand K, Hougaard DM, Schendel DE, Bent NP, Svaerke C, Thorsen P. Association of preterm birth with sustained postnatal inflammatory response Obstet Gynecol. 2008;111(5): 1118–1128.

Download references

Author information

Correspondence to Ramkumar Menon MS, PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Menon, R., Torloni, M.R., Voltolini, C. et al. Biomarkers of Spontaneous Preterm Birth: An Overview of The Literature in the Last Four Decades. Reprod. Sci. 18, 1046–1070 (2011). https://doi.org/10.1177/1933719111415548

Download citation

Keywords

  • prematurity
  • risk factors
  • prevention
  • intervention
  • cytokines
  • pathways